Elekta expands in Poland through acquisition


STOCKHOLM, March 17, 2015 – Elekta (EKTA-B.ST) has today completed its
acquisition of Polish distributor, RTA, as announced August 25,
2014 (http://www.elekta.com/pressreleases/916835/elekta-announces-intention-to
-acquire-rta-a-leading-distributor-in-poland.html). This deal will allow Elekta
to leverage RTA’s existing relationships in order to strengthen Elekta’s
position in Poland’s private and public health care sectors.
Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin
America and Middle East, says: “The radiation therapy market is growing steadily
as both private and public care providers strive to meet the need to deliver
improved treatments. Bringing RTA into the Elekta family is a natural
progression that will help meet this need and will benefit Polish cancer centers
and, ultimately, their patients.

“Elekta’s strengthened position in Poland will also enable it to increase its
presence in state-run and teaching hospitals,” he adds.

As previously stated, the acquisition of RTA is expected to add 0.3 percent to
Elekta’s revenues on an annual basis and is expected to be EPS accretive on an
annual basis.

With this finalization, RTA will change its name to Elekta and become a wholly
-owned subsidiary.

# # #

For further information, please contact:
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on March 17, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.

Attachments

03168847.pdf